BlackRock, Inc. 13D and 13G filings for Inovio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 507,219 2.300% | -1,433,125 (-73.86%) | Filing |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 1,940,343 9.300% | 419,934 (+27.62%) | Filing |
| 2022-02-01 5:08 pm Purchase | 2021-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 1,520,410 8.700% | 333,498 (+28.10%) | Filing |
| 2021-01-29 09:57 am Purchase | 2020-12-31 | 13G | Inovio Pharmaceuticals, Inc. INO | BlackRock Inc. BLK | 1,186,912 8.400% | 550,695 (+86.56%) | Filing |